Significantly higher levels of plasma biomarker of systemic inflammation, CRP and sTNFR1 was noted in patients with gout (p = 0.008 & 0.022, respectively) and RA (p = 0.037 & 0.012, respectively) as compared to OA (Table 4). This evidence concerns the gene CRP and rheumatoid arthritis.